Spencer Pharmaceutical Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Max Arella
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 15.4yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 14.4yrs |
Recent management updates
No updates
Recent updates
No updates
CEO
Max Arella (68 yo)
15.4yrs
Tenure
Dr. Maximilien Arella, Ph D., known as Max has been the Chief Executive Officer and President at Spencer Pharmaceutical Inc. since June 23, 2009. Dr. Arella has a wealth of experience in academic research,...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 15yrs | no data | no data | |
| Member of Scientific Advisory Board | 14.2yrs | no data | no data | |
| Member of Scientific Advisory Board | 14.4yrs | no data | no data |
14.4yrs
Average Tenure
Experienced Board: SPPH's board of directors are seasoned and experienced ( 14.4 years average tenure).